Physician profile
Thomas Michael Schmelzer
NPI 1558499301
$34,539.27
in general payments reported to CMS, 2019-2025
6 companies · $19K in 2025
The $19K reported for 2025 was more than what 97% of Pediatric Surgery providers received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.15 · 2020: $60.93 · 2021: $31.28 · 2022: $209 · 2023: $6,168 · 2024: $8,837 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $22K · Consulting Fee: $9,456 · Food and Beverage: $1,399 · Travel and Lodging: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $22,252.50 |
| Consulting Fee | $9,456.25 |
| Food and Beverage | $1,398.68 |
| Travel and Lodging | $1,119.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $33,015.81 | 2022-2025 | Medline, Pectus Bar Bending Forceps, Standard, Sternalock 360 System |
| Atricure, INC. | $1,434.76 | 2020-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Takeda Pharmaceuticals U.S.A., INC. | $30.50 | 2023 | Gattex |
| Kerecis Limited | $27.77 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Biotissue Holdings INC. | $19.28 | 2024 | |
| Conmed Corporation | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Schmelzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.